In our study, we demonstrate that inhibition of the mTOR pathway by Everolimus alone is sufficient to block cell growth in NRAS mutant neuroblastoma cells compared to wild type cells (Fig 3). The gene discussed is NRAS; the disease is neuroblastoma.